|Heart disease and stroke statistics—2017 update: a report from the American Heart Association|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
|Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis|
KM Mohan, CDA Wolfe, AG Rudd, PU Heuschmann, ...
Stroke 42 (5), 1489-1494, 2011
|Acute stroke therapy by inhibition of neutrophils (ASTIN) an adaptive dose-response study of UK-279,276 in acute ischemic stroke|
M Krams, KR Lees, W Hacke, AP Grieve, JM Orgogozo, GA Ford
Stroke 34 (11), 2543-2548, 2003
|Justify your alpha|
D Lakens, FG Adolfi, CJ Albers, F Anvari, MAJ Apps, SE Argamon, ...
Nature human behaviour 2 (3), 168-171, 2018
|Estimates of outcomes up to ten years after stroke: analysis from the prospective South London Stroke Register|
CDA Wolfe, SL Crichton, PU Heuschmann, CJ McKevitt, AM Toschke, ...
PLoS medicine 8 (5), e1001033, 2011
|Bayesian methods in practice: experiences in the pharmaceutical industry|
A Racine, AP Grieve, H Fluhler, AFM Smith
Applied Statistics, 93-150, 1986
|Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register|
KM Mohan, SL Crichton, AP Grieve, AG Rudd, CDA Wolfe, ...
Journal of Neurology, Neurosurgery & Psychiatry 80 (9), 1012-1018, 2009
|Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR)|
PU Heuschmann, AP Grieve, AM Toschke, AG Rudd, CDA Wolfe
Stroke 39 (8), 2204-2210, 2008
|Adaptive Bayesian designs for dose-ranging drug trials|
DA Berry, P Mueller, AP Grieve, M Smith, T Parke, R Blazek, N Mitchard, ...
Case studies in Bayesian statistics, 99-181, 2002
|A Bayesian analysis of the two-period crossover design for clinical trials|
Biometrics, 979-990, 1985
|Simulation-based sequential Bayesian design|
P Müller, DA Berry, AP Grieve, M Smith, M Krams
Journal of statistical planning and inference 137 (10), 3140-3150, 2007
|Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke|
CDA Wolfe, J Redfern, AG Rudd, AP Grieve, PU Heuschmann, C McKevitt
Stroke 41 (11), 2470-2476, 2010
|Impact of London's low emission zone on air quality and children's respiratory health: a sequential annual cross-sectional study|
IS Mudway, I Dundas, HE Wood, N Marlin, JB Jamaludin, SA Bremner, ...
The Lancet Public Health 4 (1), e28-e40, 2019
|ASTIN: a Bayesian adaptive dose–response trial in acute stroke|
AP Grieve, M Krams
Clinical Trials 2 (4), 340-351, 2005
|Aspartate aminotransferase-to-platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation|
A Grieve, E Makin, M Davenport
Journal of pediatric surgery 48 (4), 789-795, 2013
|Bayesian approach to bioequivalence assessment: an example|
H Flühler, AP Grieve, D Mandallaz, J Mau, HA Moser
Journal of pharmaceutical sciences 72 (10), 1178-1181, 1983
|Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database|
JM Nicholas, L Ridsdale, MP Richardson, AP Grieve, MC Gulliford
Seizure 22 (1), 37-42, 2013
|Cutaneous lymphocyte antigen and α4β7 T‐lymphocyte responses are associated with peanut allergy and tolerance in children|
SMH Chan, V Turcanu, AC Stephens, AT Fox, AP Grieve, G Lack
Allergy 67 (3), 336-342, 2012
|DISCUSSION ON THE MEETING ON THE GIBBS SAMPLER AND OTHER MARKOV CHAIN-MONTE CARLO METHODS|
P Clifford, C Jennison, J Wakefield, D Phillips, A Frigessi, AJ Gray, ...
J ROY STAT SOC B MET 55 (1), 53-102, 1993
|Tests of sphericity of normal distributions and the analysis of repeated measures designs|
Psychometrika 49 (2), 257-267, 1984